These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28117537)

  • 1. Persistent neuropsychiatric impairment in HCV patients despite clearance of the virus?!
    Dirks M; Pflugrad H; Haag K; Tillmann HL; Wedemeyer H; Arvanitis D; Hecker H; Tountopoulou A; Goldbecker A; Worthmann H; Weissenborn K
    J Viral Hepat; 2017 Jul; 24(7):541-550. PubMed ID: 28117537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short article: Fatigue in the long term after HCV treatment in HIV-HCV-coinfected patients: functional limitations persist despite viral clearance in patients exposed to peg-interferon/ribavirin-containing regimens (ANRS CO13-HEPAVIH cohort).
    Marcellin F; Protopopescu C; Poizot-Martin I; Miailhes P; Esterle L; Wittkop L; Spire B; Bocquier A; Salmon-Ceron D; Dabis F; Carrieri MP;
    Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):1003-7. PubMed ID: 27177169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection.
    Kallman J; O'Neil MM; Larive B; Boparai N; Calabrese L; Younossi ZM
    Dig Dis Sci; 2007 Oct; 52(10):2531-9. PubMed ID: 17406828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral eradication reduces all-cause mortality in patients with chronic hepatitis C virus infection: a propensity score analysis.
    Tada T; Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S; Yama T; Tanaka J
    Liver Int; 2016 Jun; 36(6):817-26. PubMed ID: 26787002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The relationship between emotional distress, cognitive performance and health - related quality of life in patients with hepatitis C prior to antiviral treatment].
    Rothenhäusler HB; Scherr M; Putz-Bankuti C; Kapper A; Stepan A; Baranyi A; Haas-Krammer A; Haas B; Stauber R
    Fortschr Neurol Psychiatr; 2009 Aug; 77(8):457-63. PubMed ID: 19676008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is psychosocial and cognitive dysfunction misattributed to the virus in hepatitis C infection? Select psychosocial contributors identified.
    Lowry D; Burke T; Galvin Z; Ryan JD; Russell J; Murphy A; Hegarty J; Stewart S; Crowe J
    J Viral Hepat; 2016 Aug; 23(8):584-95. PubMed ID: 27167497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus.
    Berenguer J; Alvarez-Pellicer J; Martín PM; López-Aldeguer J; Von-Wichmann MA; Quereda C; Mallolas J; Sanz J; Tural C; Bellón JM; González-García J;
    Hepatology; 2009 Aug; 50(2):407-13. PubMed ID: 19575364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Depressive symptoms during treatment with interferon alpha for HCV infection--preliminary report].
    Małyszczak K; Inglot M; Pawłowski T; Czarnecki M; Rymer W; Andrzej K
    Psychiatr Pol; 2006; 40(4):799-808. PubMed ID: 17068951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Interferon-Based Treatment on Quality of Life and Work-Related Productivity of Korean Patients with Chronic Hepatitis C.
    Ahn SH; Choe WH; Kim YJ; Heo J; Latarska-Smuga D; Kang J; Paik SW
    Gut Liver; 2020 May; 14(3):368-376. PubMed ID: 31533395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurologic Manifestations of Hepatitis C Virus Infection.
    Iriana S; Curry MP; Afdhal NH
    Clin Liver Dis; 2017 Aug; 21(3):535-542. PubMed ID: 28689591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved cognitive function as a consequence of hepatitis C virus treatment.
    Thein HH; Maruff P; Krahn MD; Kaldor JM; Koorey DJ; Brew BJ; Dore GJ
    HIV Med; 2007 Nov; 8(8):520-8. PubMed ID: 17944685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview.
    Adinolfi LE; Nevola R; Lus G; Restivo L; Guerrera B; Romano C; Zampino R; Rinaldi L; Sellitto A; Giordano M; Marrone A
    World J Gastroenterol; 2015 Feb; 21(8):2269-80. PubMed ID: 25741133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Associated with Health-Related Quality of Life in Korean Patients with Chronic Hepatitis C Infection Using the SF-36 and EQ-5D.
    Jang ES; Kim YS; Kim KA; Lee YJ; Chung WJ; Kim IH; Lee BS; Jeong SH
    Gut Liver; 2018 Jul; 12(4):440-448. PubMed ID: 29588435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Viral Eradication With Ledipasvir and Sofosbuvir, With or Without Ribavirin, on Measures of Fatigue in Patients With Chronic Hepatitis C Virus Infection.
    Gerber L; Estep M; Stepanova M; Escheik C; Weinstein A; Younossi ZM
    Clin Gastroenterol Hepatol; 2016 Jan; 14(1):156-64.e3. PubMed ID: 26241510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatigue and depressive symptoms associated with chronic viral hepatitis patients. health-related quality of life (HRQOL).
    Karaivazoglou K; Iconomou G; Triantos C; Hyphantis T; Thomopoulos K; Lagadinou M; Gogos C; Labropoulou-Karatza C; Assimakopoulos K
    Ann Hepatol; 2010; 9(4):419-27. PubMed ID: 21057161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life considerations for patients with chronic hepatitis C.
    Foster GR
    J Viral Hepat; 2009 Sep; 16(9):605-11. PubMed ID: 19674284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C.
    De Mitri MS; Morsica G; Chen CH; Mele L; Baccarini P; Chianese R; Piccinini A; Lazzarin A; Pisi E
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):255-61. PubMed ID: 9646218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon-free versus interferon-based therapy and the risk of developing hepatocellular carcinoma after eradication of hepatitis C virus in Japan.
    Toyoda H; Tada T; Takaguchi K; Senoh T; Shimada N; Hiraoka A; Michitaka K; Ishikawa T; Kumada T
    J Viral Hepat; 2017 Jun; 24(6):472-476. PubMed ID: 27983762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of neurocognitive function in responders to an antiviral therapy for chronic hepatitis C.
    Kraus MR; Schäfer A; Teuber G; Porst H; Sprinzl K; Wollschläger S; Keicher C; Scheurlen M
    Hepatology; 2013 Aug; 58(2):497-504. PubMed ID: 23300053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sofosbuvir and ledipasvir improve patient-reported outcomes in patients co-infected with hepatitis C and human immunodeficiency virus.
    Younossi ZM; Stepanova M; Sulkowski M; Naggie S; Henry L; Hunt S
    J Viral Hepat; 2016 Nov; 23(11):857-865. PubMed ID: 27291391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.